G&E Herbal Biotechnology Co (ROCO:4911) Cyclically Adjusted Book per Share: NT$13.27 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4911 G&E Herbal Biotechnology Co Ltd ROCO:4911
70 GF Score
Price NT$29.85
GF Value NT$44.04
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is G&E Herbal Biotechnology Co Cyclically Adjusted Book per Share?

G&E Herbal Biotechnology Co ROCO:4911 70 Cyclically Adjusted Book per Share is NT$13.27 as of Jun. 2026. GuruFocus rates ROCO:4911 with a GF Score™ of 70/100 and a GF Value™ of NT$44.04 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

G&E Herbal Biotechnology Co's adjusted book value per share for the three months ended in Jun. 2026 was NT$12.737. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$13.27 for the trailing ten years ended in Jun. 2026.

During the past 12 months, G&E Herbal Biotechnology Co's average Cyclically Adjusted Book Growth Rate was 1.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -0.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of G&E Herbal Biotechnology Co was 2.00% per year. The lowest was -0.20% per year. And the median was 1.05% per year.

As of today (2026-09-05), G&E Herbal Biotechnology Co's current stock price is NT$29.85. G&E Herbal Biotechnology Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was NT$13.27. G&E Herbal Biotechnology Co's Cyclically Adjusted PB Ratio of today is 2.25.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of G&E Herbal Biotechnology Co was 4.99. The lowest was 1.41. And the median was 3.02.


G&E Herbal Biotechnology Co  (ROCO:4911) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

G&E Herbal Biotechnology Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=29.85/13.27
=2.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of G&E Herbal Biotechnology Co was 4.99. The lowest was 1.41. And the median was 3.02.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


G&E Herbal Biotechnology Co Cyclically Adjusted Book per Share Related Terms


G&E Herbal Biotechnology Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for G&E Herbal Biotechnology Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G&E Herbal Biotechnology Co Cyclically Adjusted Book per Share Chart

G&E Herbal Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.84 13.09 13.08 13.01 13.03

G&E Herbal Biotechnology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.12 13.13 13.03 13.21 13.27

ROCO:4911 vs VRTX, REGN, MRNA: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, G&E Herbal Biotechnology Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G&E Herbal Biotechnology Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G&E Herbal Biotechnology Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where G&E Herbal Biotechnology Co's Cyclically Adjusted PB Ratio falls into.


ROCO:4911
70GF Score
G&E Herbal Biotechnology Co Ltd ROCO:4911
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

G&E Herbal Biotechnology Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, G&E Herbal Biotechnology Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=12.737/333.9520*333.9520
=12.737

Current CPI (Jun. 2026) = 333.9520.

G&E Herbal Biotechnology Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 11.722 241.428 16.214
201612 11.696 241.432 16.178
201703 11.512 243.801 15.769
201706 11.548 244.955 15.744
201709 11.344 246.819 15.349
201712 11.097 246.524 15.032
201803 11.023 249.554 14.751
201806 10.932 251.989 14.488
201809 10.863 252.439 14.371
201812 10.768 251.233 14.313
201903 10.650 254.202 13.991
201906 10.561 256.143 13.769
201909 10.475 256.759 13.624
201912 10.428 256.974 13.552
202003 10.371 258.115 13.418
202006 10.297 257.797 13.339
202009 10.248 260.280 13.149
202012 10.220 260.474 13.103
202103 10.172 264.877 12.825
202106 10.105 271.696 12.420
202109 10.060 274.310 12.247
202112 9.931 278.802 11.895
202203 9.859 287.504 11.452
202206 9.816 296.311 11.063
202209 9.900 296.808 11.139
202212 10.039 296.797 11.296
202303 10.258 301.836 11.349
202306 10.500 305.109 11.493
202309 10.823 307.789 11.743
202312 11.091 306.746 12.075
202403 11.376 312.332 12.163
202406 11.257 314.175 11.966
202409 11.658 315.301 12.348
202412 12.112 315.605 12.816
202503 12.643 319.799 13.203
202506 12.564 322.561 13.008
202509 13.089 324.800 13.458
202512 13.486 324.054 13.898
202603 13.702 330.213 13.857
202606 12.737 333.952 12.737

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$13.27 mean?
G&E Herbal Biotechnology Co (ROCO:4911) has a Cyclically Adjusted Book per Share of NT$13.27 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on G&E Herbal Biotechnology Co and its competitors.
Is G&E Herbal Biotechnology Co's Cyclically Adjusted Book per Share too high?
G&E Herbal Biotechnology Co's current Cyclically Adjusted Book per Share is NT$13.27. Overall, G&E Herbal Biotechnology Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does G&E Herbal Biotechnology Co's Cyclically Adjusted Book per Share compare to VRTX and REGN?
G&E Herbal Biotechnology Co's Cyclically Adjusted Book per Share of NT$13.27 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on G&E Herbal Biotechnology Co and its competitors. G&E Herbal Biotechnology Co's current Cyclically Adjusted Book per Share is NT$13.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is G&E Herbal Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, G&E Herbal Biotechnology Co (ROCO:4911) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$44.04, compared to a current price of NT$29.85 — trading 32.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$13.27. G&E Herbal Biotechnology Co's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For G&E Herbal Biotechnology Co (ROCO:4911), the current Cyclically Adjusted Book per Share is NT$13.27 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is G&E Herbal Biotechnology Co (ROCO:4911) Overvalued in 2026?

Based on GuruFocus' analysis, G&E Herbal Biotechnology Co stock appears to be undervalued. The current stock price of NT$29.85 is trading 32.2% below its estimated GF Value™ of NT$44.04. GuruFocus considers G&E Herbal Biotechnology Co to be Significantly Undervalued.

Key valuation signals for ROCO:4911:

  • Cyclically Adjusted Book per Share: NT$13.27
  • GF Value™: NT$44.04 vs. price of NT$29.85 (32.2% below fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4911 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


G&E Herbal Biotechnology Co Business Description

Address No. 92, Keji 5th Road, Annan District, Tainan, TWN, 709015
G&E Herbal Biotechnology Co Ltd is a Taiwan-based biopharmaceutical company. It specializes in the production of Western conventional drugs, Chinese traditional drugs, unclassified food, cosmetics, and health products. The company is focused on botanical extraction technology and products. Its products include botanical extract toner, total moisture conditioning cream, whitening clear cream, and firming essence cream.
70GF Score

Get the complete analysis for ROCO:4911

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$29.85
Price
NT$44.04
GF Value